Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Safety and tolerability of caspofungin acetate in the treatment of fungal infections.
Sable CA, Nguyen BY, Chodakewitz JA, DiNubile MJ. Sable CA, et al. Among authors: chodakewitz ja. Transpl Infect Dis. 2002 Mar;4(1):25-30. doi: 10.1034/j.1399-3062.2002.01004.x. Transpl Infect Dis. 2002. PMID: 12123423 Review.
Pharmacokinetics, safety, and tolerability of phentermine in healthy participants receiving taranabant, a novel cannabinoid-1 receptor (CB1R) inverse agonist.
Addy C, Jumes P, Rosko K, Li S, Li H, Maes A, Johnson-Levonas AO, Chodakewitz J, Stoch SA, Wagner JA. Addy C, et al. Among authors: chodakewitz j. J Clin Pharmacol. 2009 Oct;49(10):1228-38. doi: 10.1177/0091270009341651. J Clin Pharmacol. 2009. PMID: 19783715 Clinical Trial.
Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies.
Krishna R, Anderson MS, Bergman AJ, Jin B, Fallon M, Cote J, Rosko K, Chavez-Eng C, Lutz R, Bloomfield DM, Gutierrez M, Doherty J, Bieberdorf F, Chodakewitz J, Gottesdiener KM, Wagner JA. Krishna R, et al. Among authors: chodakewitz j. Lancet. 2007 Dec 8;370(9603):1907-14. doi: 10.1016/S0140-6736(07)61813-3. Lancet. 2007. PMID: 18068514 Clinical Trial.
Effect of telcagepant on spontaneous ischemia in cardiovascular patients in a randomized study.
Behm MO, Blanchard RL, Murphy MG, Palcza JS, Harris DE, Butterfield KL, Smith WB, Preston RA, Chodakewitz JA, Krucoff MW. Behm MO, et al. Among authors: chodakewitz ja. Headache. 2011 Jun;51(6):954-60. doi: 10.1111/j.1526-4610.2011.01901.x. Headache. 2011. PMID: 21631478 Clinical Trial.
Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A.
Marr KA, Hachem R, Papanicolaou G, Somani J, Arduino JM, Lipka CJ, Ngai AL, Kartsonis N, Chodakewitz J, Sable C. Marr KA, et al. Among authors: chodakewitz j. Transpl Infect Dis. 2004 Sep;6(3):110-6. doi: 10.1111/j.1399-3062.2004.00065.x. Transpl Infect Dis. 2004. PMID: 15569226
Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort.
Hiemenz JW, Raad II, Maertens JA, Hachem RY, Saah AJ, Sable CA, Chodakewitz JA, Severino ME, Saddier P, Berman RS, Ryan DM, Dinubile MJ, Patterson TF, Denning DW, Walsh TJ. Hiemenz JW, et al. Among authors: chodakewitz ja. Eur J Clin Microbiol Infect Dis. 2010 Nov;29(11):1387-94. doi: 10.1007/s10096-010-1013-0. Epub 2010 Aug 12. Eur J Clin Microbiol Infect Dis. 2010. PMID: 20703506 Clinical Trial.
Effects of omeprazole on plasma levels of raltegravir.
Iwamoto M, Wenning LA, Nguyen BY, Teppler H, Moreau AR, Rhodes RR, Hanley WD, Jin B, Harvey CM, Breidinger SA, Azrolan N, Farmer HF Jr, Isaacs RD, Chodakewitz JA, Stone JA, Wagner JA. Iwamoto M, et al. Among authors: chodakewitz ja. Clin Infect Dis. 2009 Feb 15;48(4):489-92. doi: 10.1086/596503. Clin Infect Dis. 2009. PMID: 19143531
Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men.
Sun H, Kennedy WP, Wilbraham D, Lewis N, Calder N, Li X, Ma J, Yee KL, Ermlich S, Mangin E, Lines C, Rosen L, Chodakewitz J, Murphy GM. Sun H, et al. Among authors: chodakewitz j. Sleep. 2013 Feb 1;36(2):259-67. doi: 10.5665/sleep.2386. Sleep. 2013. PMID: 23372274 Free PMC article. Clinical Trial.
Effect of different durations and formulations of diltiazem on the single-dose pharmacokinetics of midazolam: how long do we go?
Friedman EJ, Fraser IP, Wang YH, Bergman AJ, Li CC, Larson PJ, Chodakewitz J, Wagner JA, Stoch SA. Friedman EJ, et al. Among authors: chodakewitz j. J Clin Pharmacol. 2011 Nov;51(11):1561-70. doi: 10.1177/0091270010387141. Epub 2011 Jan 5. J Clin Pharmacol. 2011. PMID: 21209240 Clinical Trial.
Metabolism and excretion of [14C]taranabant, a cannabinoid-1 inverse agonist, in humans.
Karanam B, Addy C, Bateman T, Reddy VB, Li S, Dean D, Li H, Jones A, Schenk D, Zhang AS, Braun M, Freeman A, Flach S, Stoch A, Chodakewitz J, Wagner JA, Kumar S. Karanam B, et al. Among authors: chodakewitz j. Xenobiotica. 2010 Oct;40(10):691-700. doi: 10.3109/00498254.2010.509820. Xenobiotica. 2010. PMID: 20722472
23 results
Jump to page
Feedback